Winston Pharmaceuticals, Inc. 4
4 · Winston Pharmaceuticals, Inc. · Filed Oct 19, 2009
Insider Transaction Report
Form 4
Phillips Scott B.
DirectorSVP, Scientific Affairs
Transactions
- Sale
Common Stock
2009-10-16$0.77/sh−6,500$5,005→ 650,157 total - Exercise/Conversion
Common Stock
2009-10-16$0.28/sh+25,000$7,000→ 661,657 total - Exercise of In-Money
Common Stock Options
2009-10-16−25,000→ 0 totalExercise: $0.28From: 2000-10-18Exp: 2009-10-18→ Common Stock (25,000 underlying) - Sale
Common Stock
2009-10-16$0.58/sh−13,500$7,830→ 636,657 total
Footnotes (1)
- [F1]Reported amount excludes: (i) options to purchase 205,193 shares of the Company's common stock, initially exercisable on 12/10/2003 and expiring on 12/10/2012, at an exercise price of $0.33; (ii) options to purchase 231,670 shares of the Company's common stock, initially exercisable on 01/12/2005 and expiring on 01/12/2014, at an exercise price of $0.33; (iii) options to purchase 661,913 shares of the Company's common stock, initially exercisable on 04/06/2006 and expiring on 04/06/2015, at an exercise price of $0.34; (iv) options to purchase 50,000 shares of the Company's common stock, initially exercisable on 04/07/2010 and expiring on 04/07/2019, at an exercise price of $1.53; and (v) options to purchase 372,147 shares of the Company common stock, initially exercisable on 10/18/2000, which options expired on 10/18/2009.